ImmunityBio, Inc. — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-06-05

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-05	Common Stock	S	28925	$3.7455	Disposed	372251	Indirect
2018-06-06	Common Stock	S	23574	$3.7869	Disposed	348677	Indirect
2018-06-07	Common Stock	S	26957	$3.6582	Disposed	321720	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	246280	Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 28,925 shares sold in the price range of $3.74 to $3.79 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Represents the weighted average share price of an aggregate total of 23,574 shares sold in the price range of $3.77 to $3.815 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 26,957
shares sold in the price range of $3.62 to $3.75 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.